Professor Willcox, distinguished UNSW School of Optometry & Vision Science microbiologist, has achieved remarkable recognition in the field of microbiology. His groundbreaking work has earned him prestigious awards and accolades from various institutions.

Professor Willcox’s expertise spans several critical areas, including ocular microbiology, ocular microbiome, ocular inflammation and infection, bio-prospecting, contact lenses, disinfectants, and the development of novel antimicrobials. His research focuses on combating infections associated with medical devices, such as contact lenses and other ocular products.

His contributions have been recognized globally, and he has been ranked as one of the top microbiology scientists worldwide. Specifically, Professor Willcox holds the impressive position of #47 in Australia and #1520 worldwide based on H-index papers and citations for academic publications in the field of Microbiology.

These rankings reflect the impact of his research and the significance of his scientific contributions. His work has not only advanced our understanding of microbial interactions but also paved the way for innovative solutions to prevent and treat infections.

Professor Willcox’s dedication to improving healthcare outcomes extends beyond academia. He actively collaborates with industry partners to develop new antimicrobial coatings for medical devices, aiming to reduce the risk of infections associated with their use. His research has the potential to benefit millions of patients worldwide.

In addition to his impressive rankings, Professor Willcox has received prestigious awards, including recognition from the American Optometric Association (AOA) and the National Health and Medical Research Council (NHMRC). His commitment to advancing medical science and improving patient care is truly commendable.

For full microbiology ranking for Australia please see here:

The full world ranking is available here:

Congratulations Mark, on your outstanding achievements! Your work continues to inspire and shape the future of microbiology and healthcare.